Found 11 matching trials
Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
PHASE3This study will examine the safety and efficacy of the addition of sitaglip...
Location
Multiple Locations
Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients
PHASE3This study is being carried out to see if dapagliflozin in addition to glim...
A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone
PHASE3The purpose of this clinical research study is to learn whether Saxagliptin...
Location
Winston Technology, Inc.
Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone
PHASE3The purpose of this clinical research study is to learn whether Saxagliptin...
Location
Local Institution
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
PHASE3The purpose of this trial is to understand if adding saxagliptin to metform...
Location
East Bay Clinical Trial Center
A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)
PHASE2A study of different doses of MK-0431 in participants with type 2 diabetes ...
Location
Multiple Locations
INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes
PHASE4T2DM has become an American Epidemic. Currently 8% of the US population has...
MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
PHASE3A study to evaluate the efficacy and safety of sitagliptin and pioglitazone...
Location
Multiple Locations
Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus
PHASE3The purpose of this study is to determine the safety and efficacy of an inv...
Location
Multiple Locations
Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus
PHASE3This is a 26-week, multicenter, randomized, double-blind, placebo and activ...
Location
Multiple Locations